Thieno [2,3-b] Pyridine Compounds with mGluR Activity
申请人:Gyertyan Istvan
公开号:US20090326002A1
公开(公告)日:2009-12-31
Provided herein are Thieno[2,3-b]pyridine compounds with mGluR activity. Also provided herein are processes and intermediates for the preparation of the Thieno[2,3-b]pyridine compounds, pharmaceutical compositions containing these compounds, and the use of these compounds in treatment, therapy, and/or prevention of conditions which require modulation of mGluR1 and mGluR5 receptors.
Thieno [2,3-b] pyridine compounds with mGluR activity
申请人:Richter Gedeon Nyrt.
公开号:US08263773B2
公开(公告)日:2012-09-11
Provided herein are Thieno[2,3-b]pyridine compounds with mGluR activity. Also provided herein are processes and intermediates for the preparation of the Thieno[2,3-b]pyridine compounds, pharmaceutical compositions containing these compounds, and the use of these compounds in treatment, therapy, and/or prevention of conditions which require modulation of mGluR1 and mGluR5 receptors.
[EN] THIENO [2,3-B] PYRIDINE COMPOUNDS WITH MGLUR ACTIVITY<br/>[FR] COMPOSÉS THIÉNO[2,3-B]PYRIDINES PRÉSENTANT UNE ACTIVITÉ DE MGLUR
申请人:RICHTER GEDEON NYRT
公开号:WO2010001185A1
公开(公告)日:2010-01-07
A compound of formula (I), wherein X is Cl or F or hydrates, solvates, or salts thereof for use treating of mGluR1 and mGluR5 receptor-mediated disorders.